Literature DB >> 16831966

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Daniel Weintraub1, Andrew D Siderowf, Marc N Potenza, Joseph Goveas, Knashawn H Morales, John E Duda, Paul J Moberg, Matthew B Stern.   

Abstract

OBJECTIVE: To determine the frequency and correlates of impulse control disorders (ICDs) in Parkinson disease (PD).
DESIGN: An unstructured screening interview for ICDs (compulsive gambling, buying, and sexual behavior) followed by a telephone-administered structured interview for screen-positive patients.
SETTING: Two university-affiliated movement disorders centers. PARTICIPANTS: A convenience sample of 272 patients with idiopathic PD who were screened for psychiatric complications. MAIN OUTCOME MEASURES: Presence of compulsive gambling, buying, or sexual behavior as assessed by the Minnesota Impulsive Disorders Interview.
RESULTS: Eighteen patients (6.6%) with PD met criteria for an ICD at some point during the course of PD, including 11 (4.0%) with an active ICD. Compulsive gambling and compulsive sexual behavior were equally common. In a multivariate model, treatment with a dopamine agonist (P = .01) and a history of ICD symptoms prior to PD onset (P = .02) predicted current ICD. There were no differences between the dopamine agonists in their association with ICDs (P = .21), and daily doses of dopamine agonists were higher in patients with an ICD than in dopamine agonist-treated patients without an ICD (P < .001).
CONCLUSIONS: Patients with PD treated with a dopamine agonist should be made aware of the risk of developing an ICD and monitored clinically. Because dopamine agonists are increasingly being used for other indications, future research should assess the dopamine agonist-associated risk for ICDs in other populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831966      PMCID: PMC1761054          DOI: 10.1001/archneur.63.7.969

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  12 in total

Review 1.  An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

Authors:  C W Olanow; R L Watts; W C Koller
Journal:  Neurology       Date:  2001-06       Impact factor: 9.910

2.  Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lorenz; Meike Steinbach; Stefan Klebe; Wolfgang Hamel; Bettina Schrader; Dieter Weinert; Dieter Müller; Hubertus M Mehdorn; Günther Deuschl
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

3.  Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.

Authors:  E Driver-Dunckley; J Samanta; M Stacy
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

4.  Taking chances: problem gamblers and mental health disorders--results from the St. Louis Epidemiologic Catchment Area Study.

Authors:  R M Cunningham-Williams; L B Cottler; W M Compton; E L Spitznagel
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

5.  Pathological gambling caused by drugs used to treat Parkinson disease.

Authors:  M Leann Dodd; Kevin J Klos; James H Bower; Yonas E Geda; Keith A Josephs; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2005-07-11

6.  Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.

Authors:  Douglas E Hobson; Anthony E Lang; W R Wayne Martin; Ajmal Razmy; Jean Rivest; Jonathan Fleming
Journal:  JAMA       Date:  2002 Jan 23-30       Impact factor: 56.272

7.  Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

Authors:  J A Molina; M J Sáinz-Artiga; A Fraile; F J Jiménez-Jiménez; C Villanueva; M Ortí-Pareja; F Bermejo
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

8.  Impulse control disorders in adult psychiatric inpatients.

Authors:  Jon E Grant; Laura Levine; Daniel Kim; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

9.  Compulsive buying: descriptive characteristics and psychiatric comorbidity.

Authors:  G A Christenson; R J Faber; M de Zwaan; N C Raymond; S M Specker; M D Ekern; T B Mackenzie; R D Crosby; S J Crow; E D Eckert
Journal:  J Clin Psychiatry       Date:  1994-01       Impact factor: 4.384

10.  Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.

Authors:  Kevin J Klos; James H Bower; Keith A Josephs; Joseph Y Matsumoto; J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2005-09       Impact factor: 4.891

View more
  173 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Management of sexual dysfunction in Parkinson's disease.

Authors:  Gila Bronner; David B Vodušek
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

3.  Pramipexole and compulsive masturbation.

Authors:  Randy A Sansone; Mark Ferlan
Journal:  Psychiatry (Edgmont)       Date:  2007-09

4.  Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

Authors:  Daniel Weintraub; Eugenia Mamikonyan; Kimberly Papay; Judith A Shea; Sharon X Xie; Andrew Siderowf
Journal:  Mov Disord       Date:  2011-12-01       Impact factor: 10.338

Review 5.  Introduction to behavioral addictions.

Authors:  Jon E Grant; Marc N Potenza; Aviv Weinstein; David A Gorelick
Journal:  Am J Drug Alcohol Abuse       Date:  2010-09       Impact factor: 3.829

6.  Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.

Authors:  Hengyi Rao; Eugenia Mamikonyan; John A Detre; Andrew D Siderowf; Matthew B Stern; Marc N Potenza; Daniel Weintraub
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

7.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

8.  Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.

Authors:  Karina L Bienfait; Matthew Menza; Margery H Mark; Roseanne D Dobkin
Journal:  J Clin Neurosci       Date:  2010-02-19       Impact factor: 1.961

9.  The Neuropsychopharmacology of Pathological Gambling.

Authors:  Kourosh Zakeri; Marc N Potenza
Journal:  Curr Psychiatry Rev       Date:  2012-02-01

10.  Prevalence of problem and pathological gambling in Parkinson's disease.

Authors:  David Crockford; Jeremy Quickfall; Shawn Currie; Sarah Furtado; Oksana Suchowersky; Nady El-Guebaly
Journal:  J Gambl Stud       Date:  2008-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.